Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Patient research partners (PRPs) are people living with a relevant disease who actively contribute to research. Their contribution is beneficial for any research project. Although the inclusion of PRPs in rheumatology research is increasingly recommended, its practical implementation, particularly in translational research, remains limited . Enhancing PRP engagement requires a clear understanding of the necessary steps.

Objective: This study aims to show steps to achieve successful collaboration between PRPs and researchers in clinical and transitional research in rheumatology.

Methods: We established a PRP network by following five main steps: setting up infrastructure, recruitment, training, PRP involvement at an early stage, and ongoing support. We adhered to overall principles of openness, feedback, and regular evaluations to create a respectful and collaborative environment. The initiative was qualitatively assessed via an online questionnaire developed by each six researchers and PRPs.

Results: Communicating our initiative at laboratory open days and to patient associations has enabled to create a network of 66 PRPs. A match-making tool was introduced to allocate interested PRPs with a project request. This led to PRP involvement in 15 projects, including 9 in translational research. Two PRP-coordinators provided support including glossaries and educational courses .

Conclusion: Our initiative outlines five essential steps for establishing PRP collaboration in rheumatology research, including translational research. This approach benefited both PRPs and researchers and might serve as a guide for other centres.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11815435PMC
http://dx.doi.org/10.1136/rmdopen-2024-005263DOI Listing

Publication Analysis

Top Keywords

prps researchers
8
prp involvement
8
including translational
8
prps
6
prp
5
build framework
4
framework establish
4
establish patient
4
patient partner
4
partner network
4

Similar Publications

Unlabelled: Packaging can be a major source of food contamination. To ensure the safety of the final packaging for the food industry, it is imperative to undertake a thorough assessment of potential contaminants that may come into contact with the food. This examination begins with evaluating the materials used in the production process of the packaging.

View Article and Find Full Text PDF

Platelet-rich plasma-contained drug delivery systems to treat orthopedic injuries.

Int J Pharm X

December 2025

Department of Chemical and Biological Engineering, Iowa State University, Ames, IA 50011, United States.

Orthopedic disorders affecting bones, joints, muscles, tendons, and other tissues are prevalent among outpatients, often caused by trauma, sports, or tumor removal. Surgical intervention is common but may yield unsatisfactory results due to limited regenerative capacity and poor blood supply. Platelet-rich plasma (PRP), an autologous biocomponent, has been clinically applied in tissue regeneration and repair, yet it faces challenges such as unclear mechanisms, side effects, and uncontrollable release.

View Article and Find Full Text PDF

Colostrum is a nutrient-rich fluid secreted by mammals shortly after birth, primarily to provide passive immunity and support early immune development in newborns. Among its various sources, bovine colostrum is the most widely used supplement due to its high bioavailability, safety profile, and clinically supported health benefits. Rich in immunoglobulins, lactoferrin, growth factors, and antimicrobial peptides, bovine colostrum exhibits diverse biological activities that extend beyond neonatal health.

View Article and Find Full Text PDF

The production of reactive oxygen species (ROS) and oxidative stress are central to the pathophysiology of diabetic wounds. This environment arises from the interplay of hyperglycemia, mitochondrial dysfunction, and chronic inflammation, leading to persistent damage. This hypothesis paper explores the therapeutic potential of Platelet-Rich Plasma (PRP) for accelerating diabetic wound healing.

View Article and Find Full Text PDF

Patient research partners in core outcome set development: a systematic review.

J Clin Epidemiol

August 2025

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Background And Objectives: A core outcome set (COS) is a minimal set of outcomes that clinical trials in a specific health or health-care area should report. Patient research partners (PRPs) should engage in all stages of COS development (coleading and codeveloping the COS). PRPs contribute the lived experience of a condition, and this perspective can improve the quality and uptake of COSs.

View Article and Find Full Text PDF